Hikma Pharmaceuticals PLC HKMPY

Set alert

Price alert · HKMPY

All alert types
46.50 USD +0.77 +1.68%

At close · Oct 30

46.50 Day range 46.50
31.80 52-week range 49.31
YTD
+10.90%
1 year
-4.12%
Open
46.50
Prev close
45.73
Mkt cap
4.81B
Vol
114
Avg vol
256
EPS
3.52
P/E
13.21
More statistics
Low
46.50
High
46.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for HKMPY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.71 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 4

Valuation

P/E 11.5×
FY 2016: 33.0×FY 2017: -4.4×FY 2018: 19.2×FY 2019: 12.8×FY 2020: 18.7×FY 2021: 16.6×FY 2022: 22.0×FY 2023: 26.7×FY 2024: 15.4×FY 2025: 11.5×
FY 2016 5y median 16.6× FY 2025
P/S 1.4×
FY 2016: 2.6×FY 2017: 1.9×FY 2018: 2.6×FY 2019: 2.8×FY 2020: 3.5×FY 2021: 2.7×FY 2022: 1.6×FY 2023: 1.8×FY 2024: 1.8×FY 2025: 1.4×
FY 2016 5y median 1.8× FY 2025
P/B 1.8×
FY 2016: 2.1×FY 2017: 2.5×FY 2018: 3.2×FY 2019: 2.9×FY 2020: 3.8×FY 2021: 2.8×FY 2022: 1.9×FY 2023: 2.3×FY 2024: 2.4×FY 2025: 1.8×
FY 2016 5y median 2.3× FY 2025
P/FCF 28.5×
FY 2016: 50.0×FY 2017: 12.7×FY 2018: 18.6×FY 2019: 21.8×FY 2020: 33.7×FY 2021: 17.0×FY 2022: 13.6×FY 2023: 12.5×FY 2024: 16.8×FY 2025: 28.5×
FY 2016 5y median 16.8× FY 2025
EV/EBITDA 7.5×
FY 2016: 15.3×FY 2017: -7.9×FY 2018: 12.7×FY 2019: 10.1×FY 2020: 11.6×FY 2021: 9.9×FY 2022: 7.4×FY 2023: 10.7×FY 2024: 9.2×FY 2025: 7.5×
FY 2016 5y median 9.2× FY 2025
EV/Sales 1.8×
FY 2016: 3.0×FY 2017: 2.2×FY 2018: 2.8×FY 2019: 2.9×FY 2020: 3.7×FY 2021: 2.9×FY 2022: 2.0×FY 2023: 2.1×FY 2024: 2.1×FY 2025: 1.8×
FY 2016 5y median 2.1× FY 2025
FCF Yield 3.5%
FY 2016: 2.0%FY 2017: 7.9%FY 2018: 5.4%FY 2019: 4.6%FY 2020: 3.0%FY 2021: 5.9%FY 2022: 7.4%FY 2023: 8.0%FY 2024: 5.9%FY 2025: 3.5%
FY 2016 5y median 5.9% FY 2025

Profitability

Gross Margin 42.9%
FY 2016: 50.6%FY 2017: 49.9%FY 2018: 50.7%FY 2019: 52.0%FY 2020: 51.3%FY 2021: 51.0%FY 2022: 49.2%FY 2023: 48.9%FY 2024: 45.3%FY 2025: 42.9%
FY 2016 5y median 48.9% FY 2025
Operating Margin 17.0%
FY 2016: 15.5%FY 2017: -38.6%FY 2018: 17.9%FY 2019: 22.3%FY 2020: 24.7%FY 2021: 22.8%FY 2022: 11.2%FY 2023: 12.8%FY 2024: 19.6%FY 2025: 17.0%
FY 2016 5y median 17.0% FY 2025
Net Margin 12.0%
FY 2016: 7.9%FY 2017: -43.5%FY 2018: 13.6%FY 2019: 22.0%FY 2020: 18.4%FY 2021: 16.5%FY 2022: 7.5%FY 2023: 6.6%FY 2024: 11.5%FY 2025: 12.0%
FY 2016 5y median 11.5% FY 2025
ROE 15.5%
FY 2016: 6.5%FY 2017: -55.7%FY 2018: 16.7%FY 2019: 23.0%FY 2020: 20.2%FY 2021: 17.2%FY 2022: 8.8%FY 2023: 8.6%FY 2024: 15.5%FY 2025: 15.5%
FY 2016 5y median 15.5% FY 2025
ROIC 10.3%
FY 2016: 6.4%FY 2017: -27.9%FY 2018: 13.5%FY 2019: 16.1%FY 2020: 13.6%FY 2021: 12.9%FY 2022: 6.5%FY 2023: 7.2%FY 2024: 12.8%FY 2025: 10.3%
FY 2016 5y median 10.3% FY 2025
ROA 7.1%
FY 2016: 3.6%FY 2017: -24.9%FY 2018: 8.1%FY 2019: 12.4%FY 2020: 10.4%FY 2021: 9.6%FY 2022: 4.2%FY 2023: 4.1%FY 2024: 7.0%FY 2025: 7.1%
FY 2016 5y median 7.0% FY 2025

Growth (YoY)

Revenue 7.3%
FY 2016: 35.4%FY 2017: -0.7%FY 2018: 6.9%FY 2019: 6.6%FY 2020: 6.1%FY 2021: 9.1%FY 2022: -1.4%FY 2023: 14.2%FY 2024: 8.8%FY 2025: 7.3%
FY 2016 FY 2025
Operating Income -7.0%
FY 2016: -20.7%FY 2017: -347.4%FY 2018: 149.7%FY 2019: 32.9%FY 2020: 17.4%FY 2021: 0.5%FY 2022: -51.5%FY 2023: 30.1%FY 2024: 66.8%FY 2025: -7.0%
FY 2016 FY 2025
EPS (diluted) 12.4%
FY 2016: -47.2%FY 2017: -631.8%FY 2018: 133.3%FY 2019: 70.9%FY 2020: -9.5%FY 2021: 0.0%FY 2022: -53.6%FY 2023: 2.4%FY 2024: 87.2%FY 2025: 12.4%
FY 2016 FY 2025
Free Cash Flow -50.6%
FY 2016: -55.0%FY 2017: 183.5%FY 2018: -0.3%FY 2019: -1.7%FY 2020: -16.1%FY 2021: 70.4%FY 2022: -25.4%FY 2023: 32.5%FY 2024: -18.6%FY 2025: -50.6%
FY 2016 FY 2025

Financial Health

Current Ratio 1.8×
FY 2016: 1.6×FY 2017: 2.0×FY 2018: 1.9×FY 2019: 1.3×FY 2020: 1.9×FY 2021: 2.1×FY 2022: 1.9×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.1×
FY 2016: 1.1×FY 2017: 1.4×FY 2018: 1.3×FY 2019: 0.9×FY 2020: 1.1×FY 2021: 1.4×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.6×
FY 2016: 0.4×FY 2017: 0.5×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.5×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 1.6×
FY 2016: 1.8×FY 2017: -1.0×FY 2018: 0.8×FY 2019: 0.4×FY 2020: 0.8×FY 2021: 0.6×FY 2022: 1.5×FY 2023: 1.7×FY 2024: 1.5×FY 2025: 1.6×
FY 2016 5y median 1.5× FY 2025
Interest Coverage 5.4×
FY 2016: 2.9×FY 2017: -12.7×FY 2018: 6.9×FY 2019: 7.4×FY 2020: 8.4×FY 2021: 8.4×FY 2022: 4.0×FY 2023: 4.2×FY 2024: 7.0×FY 2025: 5.4×
FY 2016 5y median 5.4× FY 2025

Dividends

Dividend Yield 4.0%
FY 2016: 1.5%FY 2017: 2.1%FY 2018: 1.5%FY 2019: 1.6%FY 2020: 1.3%FY 2021: 1.7%FY 2022: 3.0%FY 2023: 2.7%FY 2024: 3.2%FY 2025: 4.0%
FY 2016 5y median 3.0% FY 2025
Payout Ratio 46.0%
FY 2016: 49.7%FY 2017: -9.4%FY 2018: 29.8%FY 2019: 20.0%FY 2020: 25.3%FY 2021: 28.5%FY 2022: 66.5%FY 2023: 72.1%FY 2024: 48.7%FY 2025: 46.0%
FY 2016 5y median 48.7% FY 2025

Annual · latest fiscal year ends 2025-12-31